APPBP2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.597600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.709000E-01
Normal-vs-Stage2
4.608200E-01
Normal-vs-Stage3
1.411760E-02
Normal-vs-Stage4
5.388200E-01
Stage1-vs-Stage2
1.068030E-01
Stage1-vs-Stage3
6.725700E-02
Stage1-vs-Stage4
5.103400E-01
Stage2-vs-Stage3
1.813440E-01
Stage2-vs-Stage4
7.179800E-01
Stage3-vs-Stage4
2.301600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.230800E-01
Normal-vs-AfricanAmerican
7.642000E-01
Normal-vs-Asian
3.949600E-01
Caucasian-vs-AfricanAmerican
1.592580E-01
Caucasian-vs-Asian
5.905800E-01
AfricanAmerican-vs-Asian
1.754560E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.223000E-01
Normal-vs-Female
6.245200E-01
Male-vs-Female
4.618400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.769200E-01
Normal-vs-Age(41-60Yrs)
9.833000E-01
Normal-vs-Age(61-80Yrs)
3.818000E-01
Normal-vs-Age(81-100Yrs)
1.416020E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.898200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.098360E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.889700E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.015800E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.833780E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.304800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.166570E-01
Normal-vs-Daily Drinker
9.863900E-02
Normal-vs-Weekly Drinker
2.568800E-01
Normal-vs-Occasional Drinker
8.390600E-01
Normal-vs-Social Drinker
8.962400E-01
Non Drinker-vs-Daily Drinker
7.888800E-01
Non Drinker-vs-Weekly Drinker
7.126800E-01
Non Drinker-vs-Occasional Drinker
1.113410E-01
Non Drinker-vs-Social Drinker
4.306300E-02
Daily Drinker-vs-Weekly Drinker
5.811600E-01
Daily Drinker-vs-Occasional Drinker
8.840400E-02
Daily Drinker-vs-Social Drinker
3.454000E-02
Weekly Drinker-vs-Occasional Drinker
2.628000E-01
Weekly Drinker-vs-Social Drinker
1.003760E-01
Occasional Drinker-vs-Social Drinker
5.697000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.677810E-01
Normal-vs-Grade 2
1.345160E-01
Normal-vs-Grade 3
1.043850E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.967760E-01
Grade 1-vs-Grade 3
2.386600E-01
Grade 1-vs-Grade 4
1.677810E-01
Grade 2-vs-Grade 3
9.168400E-01
Grade 2-vs-Grade 4
1.345160E-01
Grade 3-vs-Grade 4
1.043850E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.172800E-01
Normal-vs-NonDiabetic
4.909600E-01
Diabetic-vs-NonDiabetic
3.576600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.081000E-01
Normal-vs-NoPancreatitis
4.732600E-01
Pancreatitis-vs-NoPancreatitis
9.139800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.596800E-01
Normal-vs-N1
4.648400E-01
N0-vs-N1
6.436600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.487800E-01
Normal-vs-TP53-NonMutant
9.195600E-01
TP53-Mutant-vs-TP53-NonMutant
2.259800E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
